Simulations Plus (SLP) Signs New Partnership Agreement In China
3/18/2014 9:52:17 AM
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that it has signed a distributor agreement with the Research Institute for Liver Diseases (RILD) in Shanghai, People’s Republic of China.
Help employers find you! Check out all the jobs and post your resume.
comments powered by